1. Analyst View
2. The Japanese Pharmaceutical Market
2.1 Country Snapshot
2.2 Market Trend Analysis
2.3 Price Cuts by Government
2.4 Therapy Area Analysis
2.5 Market Share of Key Players
2.6 Market Forecast till 2013
3. What is Making Generics So Lucrative in Japan
3.1 Pressure on Government to Cut Skyrocketing Healthcare Costs
3.2 Generic Market is a large “Untapped Goldmine”
3.3 Margin from Generics is Fairly Higher than Other Developed Markets
3.4 Major Blockbusters Going Off-patent
3.5 Increasing Investment by Major Domestic and Foreign Companies
4. The Japanese Generic Market
4.1 Market Trend Analysis
4.2 Generics Substitution has been Slow so Far
4.3 Regulatory Changes and Incentives will Lead to Rapid Adoption in Future
4.4 US and European Generics Strategies will Fail in Japan
4.5 Perception about Generics is a Significant Barrier
4.6 Market Share of Key Players
4.7 Market Forecast till 2013
5. Key Players
5.1 Sawai Pharmaceuticals
5.2 Taiyo Pharmaceutical
5.3 Nichi-Iko
5.4 Towa
5.5 Nippon Chemiphar
5.6 Fuji Pharma
